(331) - Cytomegalovirus Viraemia in Intermediate-Risk Heart Transplant Recipients: A 5-Year Comparison of Universal Prophylaxis and Pre-Emptive Therapy.
Saved in:
| Title: | (331) - Cytomegalovirus Viraemia in Intermediate-Risk Heart Transplant Recipients: A 5-Year Comparison of Universal Prophylaxis and Pre-Emptive Therapy. |
|---|---|
| Authors: | Lim, R.1 (AUTHOR), Carlos, L.1 (AUTHOR), Burrows, F.1 (AUTHOR), Offen, S.1 (AUTHOR), Chiu, D.2 (AUTHOR), Eckford, H.1 (AUTHOR), Marriott, D.1 (AUTHOR), Wong, N.1 (AUTHOR), Barua, S.1 (AUTHOR), Campos Deveza e Silva, R.1 (AUTHOR), Bart, N.1 (AUTHOR), Jabbour, A.1 (AUTHOR), Kotlyar, E.1 (AUTHOR), Hayward, C.1 (AUTHOR), Keogh, A.1 (AUTHOR), MacDonald, P.1 (AUTHOR), Muthiah, K.1 (AUTHOR) |
| Source: | Journal of Heart & Lung Transplantation. Jul2026:Supplement, Vol. 45 Issue 5, p160-160. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 10532498 |
|---|---|
| DOI: | 10.1016/j.healun.2026.02.339 |
